- Home
- MRUS vs FROG Comparison
MRUS vs FROG Comparison
Compare MRUS & FROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- FROG
- Stock Information
- Founded
- MRUS 2003
- FROG 2008
- Country
- MRUS Netherlands
- FROG United States
- Employees
- MRUS N/A
- FROG N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- FROG Computer Software: Prepackaged Software
- Sector
- MRUS Health Care
- FROG Technology
- Exchange
- MRUS Nasdaq
- FROG Nasdaq
- Market Cap
- MRUS 4.1B
- FROG 3.6B
- IPO Year
- MRUS 2016
- FROG 2020
- Fundamental
- Price
- MRUS $66.82
- FROG $41.54
- Analyst Decision
- MRUS Strong Buy
- FROG Strong Buy
- Analyst Count
- MRUS 13
- FROG 19
- Target Price
- MRUS $88.54
- FROG $41.17
- AVG Volume (30 Days)
- MRUS 645.9K
- FROG 839.7K
- Earning Date
- MRUS 08-04-2025
- FROG 08-07-2025
- Dividend Yield
- MRUS N/A
- FROG N/A
- EPS Growth
- MRUS N/A
- FROG N/A
- EPS
- MRUS N/A
- FROG N/A
- Revenue
- MRUS $54,732,000.00
- FROG $450,584,000.00
- Revenue This Year
- MRUS $68.08
- FROG $19.77
- Revenue Next Year
- MRUS $0.09
- FROG $15.14
- P/E Ratio
- MRUS N/A
- FROG N/A
- Revenue Growth
- MRUS 42.77
- FROG 21.66
- 52 Week Low
- MRUS $33.19
- FROG $22.91
- 52 Week High
- MRUS $67.07
- FROG $45.10
- Technical
- Relative Strength Index (RSI)
- MRUS 77.27
- FROG 49.89
- Support Level
- MRUS $61.51
- FROG $40.94
- Resistance Level
- MRUS $64.00
- FROG $42.84
- Average True Range (ATR)
- MRUS 2.32
- FROG 1.18
- MACD
- MRUS 1.02
- FROG 0.03
- Stochastic Oscillator
- MRUS 97.35
- FROG 59.38
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.